StockVS

Haoxi Health Technology Limited (HAO) 股票分析

通信服务

Haoxi Health Technology Limited

$1.09

$-0.25 (-18.66%)

最后更新: 2026年5月26日

价格走势

分析

公司概述

Haoxi Health Technology Limited operates as a provider of online marketing solutions within the Chinese market, utilizing its subsidiaries to deliver services such as short video marketing and customized planning through various media partners. The company functions within the Communication Services sector, specifically categorized under the Advertising Agencies industry, positioning it as a specialized player in digital media distribution and content promotion. With a market capitalization of $65.98M, an annual revenue of $32.80M, and an employee count of 26, the entity represents a small-cap organization with limited headcount. These valuation and revenue figures indicate that Haoxi Health Technology is a niche operation with relatively modest scale, suggesting its market influence is concentrated in specific advertising verticals rather than broad consumer reach.

财务健康

The company reported a revenue of $32.80M for the trailing twelve months, with a net income of $3.88M and an EBITDA of $-1,705,292, highlighting a significant divergence between top-line earnings and operational cash generation. The substantial gap between the positive net income and negative EBITDA reveals a cost structure where non-operating income or other comprehensive income significantly boosts the bottom line, while core operational expenses likely exceed EBITDA calculations, possibly due to asset write-downs or one-time non-operating gains. Free cash flow stands at $-6,025,760, indicating that the company is currently consuming cash to fund its operations and growth initiatives rather than generating excess liquidity for distribution. This negative cash flow suggests a reliance on external financing or existing cash reserves to sustain day-to-day activities without immediate profitability in cash terms. Margin analysis shows a gross margin of 2.8%, an operating margin of -21.2%, and a profit margin of 11.8%, illustrating a highly leveraged cost structure where operating expenses severely erode gross profits before non-operating items turn the final profit margin positive. On the balance sheet, the company holds $8.62M in cash against $2.02M in debt, resulting in a debt-to-equity ratio of 11.63, which indicates a highly leveraged financial position despite the low absolute debt level. The current ratio of 5.05 demonstrates strong short-term liquidity, suggesting the firm possesses ample current assets to cover its current liabilities without immediate refinancing pressure. Return on equity is reported at 27.1% while return on assets is -6.7%, revealing that management is effectively leveraging equity to generate returns, although the negative asset return points to challenges in utilizing the total asset base efficiently to generate profit.

估值评估

The trailing twelve-month P/E ratio is 0.84, while the forward P/E is N/A, implying that analysts or the market do not currently project consistent future earnings per share that would support a standard forward valuation multiple. The price-to-book ratio of 0.19 indicates that the stock is trading at a significant discount to its book value, suggesting the market prices the company well below the net asset value recorded on its balance sheet. The price-to-sales ratio of 2.01 and an EV/EBITDA of 1.98 provide alternative valuation perspectives that suggest the market is not overly pessimistic about the company's sales potential relative to its enterprise value, despite the negative EBITDA. The 52-week high is $2.31 and the 52-week low is $0.82, providing a trading range within which the stock has fluctuated over the past year. Based on the provided data, the current price metrics suggest the stock is positioned within this historical range, reflecting market volatility typical of small-cap advertising firms. The beta value is -0.19, which is an anomalous negative figure indicating that the stock price has historically moved inversely to the broader market, suggesting a unique sensitivity to specific market factors rather than general market trends.

Growth & Income

Revenue growth year-over-year is -64.6%, while earnings growth year-over-year is 172.7%, demonstrating a scenario where earnings are expanding significantly faster than revenue due to the aforementioned non-operating income components. The company does not pay dividends, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning all generated profits are retained within the business rather than distributed to shareholders. Since the firm is a non-dividend payer, it effectively reinvests its earnings into its core advertising business or uses its cash reserves to manage its negative free cash flow and operational needs. The overall growth and income profile is characterized by volatile earnings driven by non-operating factors and a complete absence of dividend income, requiring investors to rely solely on potential capital appreciation for returns.

同行比较

Haoxi Health Technology Limited (HAO) 在广告代理行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
Haoxi Health Technology Limited HAO $2.01M N/A
AppLovin Corporation APP $172.75B 44.6
Omnicom Group Inc. OMC $21.21B N/A
The Trade Desk, Inc. TTD $10.43B 25.2

广告代理行业平均市盈率为34.7倍。Haoxi Health Technology Limited的市盈率为N/A。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于Haoxi Health Technology Limited

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It serves advertiser client base primarily in the healthcare industry. Haoxi Health Technology Limited was founded in 2018 and is based in Chaoyang, China.

公司简介以英文显示。

访问官网 →

关键指标

市值
$2.01M
市盈率
N/A
52周最高
$285.44
52周最低
$1.02
平均成交量
351.60K
Beta系数
-0.57

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NASDAQ
国家
China
员工数
26